As of the latest Form 4 filed Jun 22, 2026.
What Veracyte Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 24 most recent filings for VCYT.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-18 | EASTHAM KARIN Director | SSale | −529.00 | $53.55 | $28.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | EASTHAM KARIN, Director | SSale | −3.20K | $52.78 | $169K | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Miller Thomas F. Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Barr Eliav Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Bhanji Muna Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Holstein Jens Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Shafer David Brent Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | EPSTEIN ROBERT S Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | EASTHAM KARIN Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | JONES EVAN/ FA Director | AAward | +5.27K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-04 | Leite John Global Chief Commercial Off | SSale | −14.0K | $50.07 | $700K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-04 | McGuire Annie EVP, General Counsel | SSale | −1.78K | $50.12 | $89.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-04 | McGuire Annie, EVP, General Counsel | SSale | −1.40K | $49.31 | $69.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-04 | Chambers Rebecca Chief Financial Officer | SSale | −1.96K | $50.09 | $98.2K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-04 | Chambers Rebecca, Chief Financial Officer | SSale | −1.60K | $49.28 | $78.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-04 | Stapley Marc Chief Executive Officer | SSale | −138K | $50.12 | $6.92M | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-04 | Stapley Marc, Chief Executive Officer | MExercise | +138K | $36.60 | $5.05M | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Leite John Global Chief Commercial Off | FTax | −4.06K | $47.80 | $194K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | McGuire Annie EVP, General Counsel | FTax | −3.29K | $47.80 | $157K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Chambers Rebecca Chief Financial Officer | FTax | −3.69K | $47.80 | $177K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Febbo Phillip G. Chief Scientific & Med Officer | FTax | −3.73K | $47.80 | $178K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Wygant Jonathan VP, Chief Accounting Officer | FTax | −1.36K | $47.80 | $65.1K | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Stapley Marc Chief Executive Officer | FTax | −9.01K | $47.80 | $431K | Yes (planned) | Form 4 ↗ |
| 2026-04-14 | 2026-04-10 | Haas Kevin Richard Chief Dev and Tech Officer | AAward | +44.2K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also VCYT’s full analysis or the market-wide insider trading feed. The tabs above jump to VCYT’s other SEC data.
Source: SEC Form 4 filings for VCYT, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.